Intuitive Surgical, Inc.
NASDAQ:ISRGMedical - Devices
+$3.65 today
- Market cap
- $145.92B
- Beta
- 1.45
- P/E (TTM)
- 48.3
- EPS (TTM)
- $8.39
Volume 2.20M
Average 2.21M
ISRG EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Intuitive Surgical, Inc.NASDAQ: ISRG
EPS (Diluted) · Q3 FY2026 · quarter ended Sep 2026
EPS (Diluted) dips below year-ago levels
Q3 FY2026 EPS (Diluted) of $1.49 fell 23.6% year over year, behind the +10.2% change in trailing-twelve-month EPS (Diluted). Sequentially, it fell 36.6% from the prior quarter. Over 3 fiscal years it compounded at +29.2% a year.
Context
- EPS (Diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 16 analysts of $11.26 (+43.1%) for the fiscal year ending Dec 2026, a step up from the +22.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $1.49-36.6% QoQ
- Last fiscal yearDec 2025
- $7.87+22.6% YoY
- LTMSep 2026
- $8.33+10.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -23.6% | +33.8% | +57.4 pp |
| 1 year | +22.6% | +43.1% | +20.5 pp |
| 3-year CAGR | +29.2% | +21.3% | -7.9 pp |
| 5-year CAGR | +18.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 7.87 USD
- Year-over-year change
- +22.6%
- 4-year CAGR
- +14.0%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.87 | +22.6% |
| FY2024 | 2024-12-31 | 6.42 | +27.6% |
| FY2023 | 2023-12-31 | 5.03 | +37.8% |
| FY2022 | 2022-12-31 | 3.65 | -21.7% |
| FY2021 | 2021-12-31 | 4.66 | — |
EPS (Diluted) vs competitors
How ISRG compares with its peers on the latest reported figures
- ISRG's LTM Sep 2026 EPS (Diluted) of $8.33 is the 2nd highest of the 5 companies compared; the peer median is $1.61.
- Its year-over-year change of +10.2% is the 4th highest of 5, against a peer median of +39.4%.
- Over three fiscal years its annual growth of +29.2% compares with a peer median of +26.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $9.65 | +27.8% | +10.8% | |
| LTM Sep 2026 | $8.33 | +10.2% | +29.2% | |
| LTM Mar 2026 | $1.77 | -53.4% | — | |
| FY2025 | $1.44 | +53.2% | +42.3% | |
| LTM Mar 2026 | -$0.28 | +50.9% | — | |
| Peer median (excluding ISRG) | $1.61 | +39.4% | +26.6% | |
Competitors are the stored peer set for ISRG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.71B | 6.22B | 7.12B | 8.35B | 10.06B |
| Cost of Revenue | 1.75B | 2.03B | 2.39B | 2.72B | 3.42B |
| Gross Profit | 3.96B | 4.2B | 4.73B | 5.63B | 6.64B |
| Gross Margin | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% |
| Research & Development | 671M | 879M | 998.8M | 1.15B | 1.31B |
| Selling, General & Admin | 1.47B | 1.74B | 1.96B | 2.14B | 2.39B |
| Operating Expenses | 2.14B | 2.62B | 2.96B | 3.29B | 3.7B |
| Depreciation & Amortization | 310.2M | 365.8M | 454.8M | 462M | 677.1M |
| EBITDA | 2.2B | 1.97B | 2.41B | 3.14B | 3.99B |
| EBITDA Margin | 38.5% | 31.7% | 33.9% | 37.5% | 39.6% |
| Operating Income | 1.82B | 1.58B | 1.77B | 2.35B | 2.95B |
| Operating Margin | 31.9% | 25.3% | 24.8% | 28.1% | 29.3% |
| Interest Income | 69.3M | 29.7M | 192.1M | 324.9M | 365.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 69.3M | 29.7M | 192.1M | 324.9M | 365.9M |
| Income Before Tax | 1.89B | 1.61B | 1.96B | 2.67B | 3.31B |
| Pre-Tax Margin | 33.1% | 25.8% | 27.5% | 32.0% | 32.9% |
| Income Tax Expense | 162.2M | 262.4M | 141.6M | 336.3M | 434.8M |
| Net Income | 1.7B | 1.32B | 1.8B | 2.32B | 2.86B |
| Net Margin | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
| EPS (Basic) | 4.79 | 3.72 | 5.12 | 6.54 | 8.00 |
| EPS (Diluted) | 4.66 | 3.65 | 5.03 | 6.42 | 7.87 |
| Weighted Avg Shares | 356.1M | 355.7M | 351.2M | 355.2M | 356.9M |
| Weighted Avg Shares (Diluted) | 365.8M | 362M | 357.4M | 362M | 362.7M |
Intuitive Surgical, Inc.
NASDAQ:ISRG
Intrinsic Alpha fair value
Locked
Current Price
$420.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.